These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16173417)

  • 21. Deformity incidence in leprosy patients treated with multidrug therapy.
    Rao PS; Subramanian M; Subramanian G
    Indian J Lepr; 1994; 66(4):449-54. PubMed ID: 7714354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of relapse after MDT in a district in West Bengal, India.
    Haldar A; Mahapatra BS; Mundle M; Haldar S; Saha AK
    Indian J Lepr; 2003; 75(1):1-8. PubMed ID: 15253389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. International open trial of uniform multi-drug therapy regimen for 6 months for all types of leprosy patients: rationale, design and preliminary results.
    Kroger A; Pannikar V; Htoon MT; Jamesh A; Katoch K; Krishnamurthy P; Ramalingam K; Jianping S; Jadhav V; Gupte MD; Manickam P
    Trop Med Int Health; 2008 May; 13(5):594-602. PubMed ID: 18346026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective analysis of 194 leprosy cases in the Republic of Yemen.
    Mekhlafi GA; al-Qubati Y
    Indian J Lepr; 1996; 68(3):227-34. PubMed ID: 8889608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of leprosy in Agra District (U.P.) India from 2001 to 20031.
    Kumar A; Girdhar A; Girdhar BK
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):115-21. PubMed ID: 16830654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
    Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS
    Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinico-epidemiological trends of leprosy in Himachal Pradesh: a five year study.
    Jindal N; Shanker V; Tegta GR; Gupta M; Verma GK
    Indian J Lepr; 2009; 81(4):173-9. PubMed ID: 20704072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time lag between case registration and commencement of treatment in a leprosy control unit.
    Murthy PK; Subramanian M; Reddy BN; Rao PS; Neelan PN
    Indian J Lepr; 1992; 64(1):8-13. PubMed ID: 1573303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in new case-detection leprosy in Bihar, India.
    Vijayakumaran P; Prasad B; Krishnamurthy P
    Indian J Lepr; 2006; 78(2):145-51. PubMed ID: 16927849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential trend of leprosy in rural and urban area of western Maharashtra.
    Mohite RV; Mohite VR; Durgawale PM
    Indian J Lepr; 2013; 85(1):11-8. PubMed ID: 24046910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reaction cases treated at the Regional Leprosy Training and Research Institute, Aska, Orissa: a retrospective analysis.
    Santaram V; Porichha D
    Indian J Lepr; 2004; 76(4):310-20. PubMed ID: 16119141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leprosy scenario in Agra: epidemiological observations from rapid population survey 2004-06.
    Kumar A; Chakma JK; Yadav VS; Girdhar A; Girdhar BK
    J Commun Dis; 2008 Dec; 40(4):277-84. PubMed ID: 19579721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Childhood leprosy: a retrospective descriptive study from Government Medical College, Kozhikode, Kerala, India.
    Sasidharanpillai S; Binitha MP; Riyaz N; Ambooken B; Mariyath OK; George B; Janardhanan AK; Sherjeena PV
    Lepr Rev; 2014 Jun; 85(2):100-10. PubMed ID: 25255613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy.
    Chen XS; Li WZ; Jiang C; Ye GY
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):371-8. PubMed ID: 10700910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of national leprosy eradication programme in Satara District, Maharashtra.
    Mohite RV; Durgawale PM
    Indian J Lepr; 2011; 83(3):139-43. PubMed ID: 22443076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The contribution of "cure by dapsone monotherapy' to the reduction of prevalence of leprosy in the State of Orissa, India, 1983-1993.
    Patnaik PK; McDougall AC
    Indian J Lepr; 1996; 68(3):223-6. PubMed ID: 8889607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in detection of new leprosy cases at two centres in Himachal Pradesh, India: a ten-year study.
    Mahajan VK; Sharma NL; Rana P; Sood N
    Indian J Lepr; 2003; 75(1):17-24. PubMed ID: 15253391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of previously undetected leprosy cases in a defined rural and urban area of Maharashtra, Western India.
    Shetty VP; Thakar UH; D'souza E; Ghate SD; Arora S; Doshi RP; Wakade AV; Thakur DV
    Lepr Rev; 2009 Mar; 80(1):22-33. PubMed ID: 19472850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pure neuritic leprosy in India: an appraisal.
    Kumar B; Kaur I; Dogra S; Kumaran MS
    Int J Lepr Other Mycobact Dis; 2004 Sep; 72(3):284-90. PubMed ID: 15485285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress of impairment scores following commencement of chemotherapy in multibacillary leprosy patients.
    Reed NK; van Brakel WH; Reed DS
    Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):328-36. PubMed ID: 9401485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.